comparemela.com

Latest Breaking News On - Reiches capital management - Page 1 : comparemela.com

Fort Sheridan Advisors LLC Has $1 39 Million Stock Position in Abbott Laboratories (NYSE:ABT)

Fort Sheridan Advisors LLC grew its holdings in Abbott Laboratories (NYSE:ABT – Free Report) by 3.3% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 12,584 shares of the healthcare product maker’s stock after purchasing an additional 402 shares during the quarter. Fort Sheridan Advisors […]

Masters Capital Management LLC Raises Holdings in Angel Oak Mortgage REIT, Inc (NYSE:AOMR)

Masters Capital Management LLC boosted its stake in shares of Angel Oak Mortgage REIT, Inc. (NYSE:AOMR – Free Report) by 15.9% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,149,378 shares of the company’s stock after acquiring an additional 157,378 shares during the […]

Abbott Laboratories (NYSE:ABT) Shares Sold by Mairs & Power Inc

Mairs & Power Inc. trimmed its position in Abbott Laboratories (NYSE:ABT – Free Report) by 1.0% in the fourth quarter, Holdings Channel reports. The firm owned 1,285,461 shares of the healthcare product maker’s stock after selling 13,538 shares during the quarter. Abbott Laboratories accounts for 1.5% of Mairs & Power Inc.’s holdings, making the stock […]

Schroder Investment Management Group Has $105 24 Million Stake in Abbott Laboratories (NYSE:ABT)

Schroder Investment Management Group trimmed its holdings in Abbott Laboratories (NYSE:ABT – Free Report) by 9.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 956,134 shares of the healthcare product maker’s stock after selling 97,201 shares during the […]

Platform Technology Partners Has $1 43 Million Stock Position in Abbott Laboratories (NYSE:ABT)

Platform Technology Partners boosted its holdings in Abbott Laboratories (NYSE:ABT – Free Report) by 1.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 12,732 shares of the healthcare product maker’s stock after purchasing an additional 161 shares during […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.